Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Marwan Fakih, MD, City of Hope Comprehensive Cancer Center, Duarte, CA, talks about the rationale behind the SPICE study (NCT02636036) of enadenotucirev in combination with nivolumab in tumors of epithelial origin. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.